A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice

Nicoletta Eliopoulos, A. Alkhaldi, Milena Crosato, Kevin Lachapelle, Jacques Galipeau

Gene Therapy · 2003 · 57 citations · 66 references

Concepts

References

66